Nervonik

Series-B+
nervonik.com Biotech & Healthcare Los Angeles, United States Founded 2021 11-50
Total Funding $65.5M
Latest Round $52.5M Series-B+
Last Announced Apr 27, 2026
Investors 8 Backers
Decision Makers 6 Verified

About Nervonik

Explore Nervonik neuromodulation devices that are working to redefine peripheral nerve stimulation with advanced technology for high motion.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Los Angeles, United States
Year Founded 2021
Team Size 11-50
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website nervonik.com
Domain Registered Date Oct 21, 2020

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $52,500,000 · Series-B+

    fundraisingfox.com

  2. Capital Raise

    Raised $13,000,000 · Series-A

    fundraisingfox.com

  3. Milestone

    Company founded

    Los Angeles, United States

  4. Milestone

    Website domain registered

    nervonik.com

Investors & Backers

8
Amzak Health Investors
Correlation Ventures
Elevage Medical Technologies
Foothill Ventures
Life Science Angels
Lumira Ventures
Shangbay Capital
U.S. Venture Partners

Funding History

2 Rounds
Series-B+ · Apr 27, 2026
Series-A · Mar 4, 2025

Founders & Leadership

3

Aydin Babakhani

Founder

Work email & phone locked Unlock →

Jeff Kramer

Chief Scientific Officer

Work email & phone locked Unlock →

Timothy Corvi

Chief Operating Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts